Subthreshold Stimulation on Chronic Low Neck Pain Myofascial Trigger Points
Launched by BENI-SUEF UNIVERSITY · Sep 19, 2023
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new treatment method called subthreshold stimulation to help people with chronic low neck pain. This type of pain often comes from tight spots in the muscles, known as myofascial trigger points. The goal of the study is to see how this treatment affects pain levels and muscle activity in patients suffering from this condition.
To be eligible for the trial, participants must have chronic neck pain and at least one trigger point in their neck muscles. Unfortunately, individuals with certain muscle or nerve diseases will not be able to join the study. While the trial is not yet recruiting participants, those who take part can expect to receive the new treatment and be monitored for changes in their pain and muscle function. This research could help improve treatment options for those struggling with neck pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • chronic neck pain
- • One or more trigger point
- Exclusion Criteria:
- • any musculoskeletal or neuromuscular diseases
About Beni Suef University
Beni-Suef University is a prominent academic institution in Egypt dedicated to advancing medical research and clinical trials aimed at improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university fosters a multidisciplinary approach to research, engaging faculty, students, and healthcare professionals in the pursuit of scientific knowledge. The institution is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring that all clinical trials conducted under its auspices are designed to enhance patient care and contribute to the global body of medical research. Through its initiatives, Beni-Suef University aims to translate research findings into practical applications that benefit communities locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported